Related Experiment Video
Updated: Mar 30, 2026

06:45
Generation and On-Demand Initiation of Acute Ictal Activity in Rodent and Human Tissue
Published on: January 19, 2019
9.5K
[Work and epilepsy--facts and phantasies]
11 Klinik Lengg AG, Schweizerische Epilepsieklinik, Zürich.
Praxis
|November 13, 2015
Summary
Epilepsy impacts work ability due to seizures and associated symptoms, requiring careful job assessment. Regular medication is crucial, but epilepsy surgery is not recommended for workplace reintegration.
Area of Science:
- Neurology
- Occupational Medicine
- Psychiatry
Context:
- Epilepsies present multifaceted challenges impacting an individual's capacity for work and workplace reintegration.
- Seizures pose risks of injury to patients and others, necessitating a thorough understanding of job demands and seizure characteristics.
Purpose:
- To outline the comprehensive assessment required for individuals with epilepsy in the workplace.
- To emphasize the importance of considering seizure semiology, frequency, and associated symptoms in occupational evaluations.
Summary:
- Workplace assessment for epilepsy must integrate job specifics with seizure details (semiology, frequency) and co-occurring neurological, neuropsychological, and psychiatric symptoms.
- Patient adherence to antiepileptic and psychiatric pharmacotherapy is a key aspect of social insurance cooperation.
- Epilepsy surgery is not considered a viable treatment option in this context.
Impact:
- Informs occupational health professionals and social insurance systems on managing epilepsy in the workforce.
- Highlights the need for holistic patient assessment, considering both ictal and interictal symptoms for effective workplace support.
- Establishes guidelines for evaluating fitness for work and reintegration strategies for individuals with epilepsy.
Related Concept Videos
Epilepsy and Seizures: Overview
1.7K
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.7K
Seizures: Classification
2.2K
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
2.2K
Antiepileptic Drugs: Glutamate Antagonists
1.2K
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
1.2K
Antiepileptic Drugs: Potassium Channel Activators
956
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
956
Antiepileptic Drugs: Sodium Channel Blockers
2.3K
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
2.3K
Antiepileptic Drugs: Calcium Channel Blockers
1.6K
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
1.6K

